Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER

Bibliographic Details
Main Authors:	Han, D, Habte, H, Qin, Y, Takamoto, K, LaBranche, C, Montefiori, D, Cho, MW
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234363/

Similar Items

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
by: Han, D, et al.
Published: (2012)

Eliciting neutralizing antibodies with gp120 outer domain
by: Qin, Y, et al.
Published: (2012)

DNA vaccines that express the MPER of HIV-1 gp41 elicit different antibodies depending upon their transmembrane and cytoplasmic domains
by: Scott, JK, et al.
Published: (2012)

Antibody to gp41 MPER Alters Functional Properties of HIV-1 Env without Complete Neutralization
by: Kim, Arthur S., et al.
Published: (2014)

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition
by: Weissenhorn, W, et al.
Published: (2012)

Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA
by: Krebs, Shelly J., et al.
Published: (2014)

A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition
by: Lutje Hulsik, David, et al.
Published: (2013)

Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines
by: Ye, Ling, et al.
Published: (2011)

Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies
by: Ma, Ben-Jiang, et al.
Published: (2011)

Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses
by: Yi, Guohua, et al.
Published: (2013)

Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein
by: Vassell, Russell, et al.
Published: (2015)

Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
by: Rosenberg, Yvonne J., et al.
Published: (2016)

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface
by: Huang, Jinghe, et al.
Published: (2014)

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
by: Huang, Jinghe, et al.
Published: (2012)

Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop
by: Qin, Yali, et al.
Published: (2015)

HIV-1 gp41 Core with Exposed Membrane-Proximal External Region Inducing Broad HIV-1 Neutralizing Antibodies
by: Wang, Ji, et al.
Published: (2011)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
by: Verkoczy, Laurent, et al.
Published: (2014)

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
by: Ruprecht, Claudia R., et al.
Published: (2011)

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
by: Rosenberg, Yvonne, et al.
Published: (2015)

Correction: Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA
Published: (2015)

The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects
by: Huan Liu, et al.
Published: (2018-04-01)

Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1
by: Boehme, Karl W., et al.
Published: (2016)

Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
by: McCoy, Laura E., et al.
Published: (2012)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
by: Yousuf Ahmed, et al.
Published: (2017-09-01)

Designer antigens for elicitation of broadly neutralizing antibodies against HIV
by: Kok, Tuckweng, et al.
Published: (2014)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
by: Khattar, Sunil K., et al.
Published: (2013)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
by: Khattar, Sunil K., et al.
Published: (2014)

Comparison of Neutralizing Antibody Responses Elicited from Highly Diverse Polyvalent Heterotrimeric HIV-1 gp140 Cocktail Immunogens versus a Monovalent Counterpart in Rhesus Macaques
by: Bowles, Emma J., et al.
Published: (2014)

Correction: Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses
by: Yi, Guohua, et al.
Published: (2013)

Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
by: Jacob, RA, et al.
Published: (2012)

Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins
by: Zhang, Si Min, et al.
Published: (2015)

Priming with DNA encoding functional trimers and boosting with soluble trimeric protein elicited tier 2 neutralizing antibodies in non-human primates
by: Chakrabarti, BK, et al.
Published: (2012)

Rationally designed HIV envelope glycoproteins delivered in a novel adjuvant elicited more broadly reactive antigen-specific antibody responses
by: Dey, AK, et al.
Published: (2012)

Enhancing Exposure of HIV-1 Neutralization Epitopes through Mutations in gp41
by: Blish, Catherine A, et al.
Published: (2008)

Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41
by: Zhang, Mei-Yun, et al.
Published: (2012)

Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals
by: Molinos-Albert, Luis M, et al.
Published: (2014)

Broadly Neutralizing Antibodies for HIV Eradication
by: Stephenson, Kathryn E., et al.
Published: (2016)

Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike
by: Lee, Jeong Hyun, et al.
Published: (2015)

Deep sequencing reveals an association between HIV-1 subtype C mutations in gp41 MPER epitopes and mother-to-child transmission
by: Yin, L, et al.
Published: (2012)

454 pyrosequencing and bioinformatics analysis of the lineage of the broad and potent gp41-directed antibody 10e8
by: Ofek, G, et al.
Published: (2012)